Hanuveda

No — see a retinal specialist within days. New distortion of straight lines, or a new blurred or blank patch in your central vision, can mean dry AMD has converted to wet AMD. Wet AMD is treatable with injections, and early treatment matters a great deal. Vision lost while waiting does not come back. This is the one thing on this page we would want you to remember.

It is a simple square grid of lines that you look at with one eye at a time, wearing your reading glasses. If the lines look wavy, broken or missing, something has changed. It costs nothing, takes thirty seconds, and it is how conversion to treatable wet AMD gets caught early — because it is detected by you noticing, not by an appointment six months away. We give one to every AMD patient and check it at every visit.

No, and we would not try. Anti-VEGF injections are what preserve central vision in wet AMD. We understand they are unpleasant — nobody enjoys them — but delaying them to try something gentler first is how preventable vision loss happens. We will support you through them rather than around them.

We want to be precise about this. Netra Tarpana is a well-established classical therapy, generally comfortable, and it reliably improves ocular surface comfort, dryness and eye strain — which in older patients with AMD is a real benefit and can make reading easier. But it is applied to the surface of the eye and the structures around it, and the macula sits at the back of the retina, behind structures the ghee does not reach. Improved comfort is not the same as treating the retina, and we will not blur that line.

Bring it and we will check. Two things matter. First, if you smoke or have ever smoked, avoid anything containing beta-carotene — in the AREDS2 study, 2% of participants taking a beta-carotene formulation developed lung cancer, double the rate without it. Second, AREDS-type supplements only help people who already have intermediate AMD or advanced AMD in one eye. They do not prevent AMD from starting, and they do nothing for cataract. Many people take them without indication.

Not entirely, though we understand why it feels that way. AREDS2 supplementation reduces progression from intermediate to advanced AMD by about 25%. Stopping smoking matters more than any treatment. Blood pressure, weight and activity are all associated with risk. Treatments for geographic atrophy have become available since 2023 and are worth asking a retinal specialist about. And low vision rehabilitation — magnifiers, lighting, high-contrast aids — makes a substantial practical difference and is badly undersupplied. None of that is a cure, but it is not nothing.

Almost certainly not, and this is worth hearing clearly. AMD damages central vision while leaving peripheral vision intact. People with advanced AMD typically retain enough vision to move around independently, recognise shapes and manage daily life — though reading, driving and recognising faces become difficult. "Macular degeneration" and "going blind" are not the same thing, and many patients carry that fear unnecessarily.

No. This is Charles Bonnet syndrome — visual hallucinations that occur in people losing vision, in an otherwise healthy mind. The brain, deprived of visual input, generates images. It can be frightening precisely because nobody warns patients it happens. It is benign, it often lessens over time, and it is not a sign of dementia or mental illness. Tell your ophthalmologist, and tell us — you are far from alone in it.